APA (7th ed.) Citation

van de Witte, S., Nauta, J., Montomoli, E., & Weckx, J. (2018). A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses. Vaccine, 36(40), 6030-6038. https://doi.org/10.1016/j.vaccine.2018.04.043

Chicago Style (17th ed.) Citation

van de Witte, Serge, Jos Nauta, Emanuele Montomoli, and Jos Weckx. "A Phase III Randomised Trial of the Immunogenicity and Safety of Quadrivalent Versus Trivalent Inactivated Subunit Influenza Vaccine in Adult and Elderly Subjects, Assessing Both Anti-haemagglutinin and Virus Neutralisation Antibody Responses." Vaccine 36, no. 40 (2018): 6030-6038. https://doi.org/10.1016/j.vaccine.2018.04.043.

MLA (9th ed.) Citation

van de Witte, Serge, et al. "A Phase III Randomised Trial of the Immunogenicity and Safety of Quadrivalent Versus Trivalent Inactivated Subunit Influenza Vaccine in Adult and Elderly Subjects, Assessing Both Anti-haemagglutinin and Virus Neutralisation Antibody Responses." Vaccine, vol. 36, no. 40, 2018, pp. 6030-6038, https://doi.org/10.1016/j.vaccine.2018.04.043.